Computer-Aided Drug Design for Immunosuppressive Tumor Microenvironment Reprogramming: A Critical Review
International Journal of Molecular Sciences · 30.10.2026 · 27 (21) · 9766
DOI: 10.3390/ijms27219766 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.10.2026. Verfasst von Jihoon Moon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Data Science, Duksung Women's University, Seoul 01369, Republic of Korea. Hauptthemen laut MEDLINE: Tumor Microenvironment, Drug Design, Computer-Aided Design, Neoplasms. Die Arbeit nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
How can cellular interactions in solid tumors guide molecular interventions against immune suppression? This critical review examines how computer-aided drug design (CADD) connects immunosuppressive tumor microenvironment (TME) states to testable molecular hypotheses. We distinguish observational artificial intelligence (AI) predictions from molecular intervention hypotheses and examine the experimental evidence required to evaluate them. We reviewed patient-derived models, spatial and multi-omics profiling, molecular design, simulation, and pharmacology using literature identified through 15 October 2026. Adenosine-receptor antagonist discovery and generative protein-binder design illustrated how computational methods contributed to experimentally tested molecular candidates. Native-state structural studies, stromal delivery, and protein degradation broadened the approaches considered. We organized these findings into a proposed framework encompassing in vivo and patient-derived systems, multi-omics mapping, phenotyping of TME states, actionable AI integration, combination-therapy prioritization, and translational testing (IMPACT). A retrospective analysis of a phase III trial illustrated how the framework connects clinical outcomes to questions about mechanism, patient selection, and exposure. The synthesis clarifies the evidence required to connect molecular binding, target engagement, and exposure to patient benefit. IMPACT provides a structure for relating biological context to molecular design and specifying hypotheses for prospective evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Data Science, Duksung Women's University, Seoul 01369, Republic of Korea.
- Department of AI-Based Drug Development, Duksung Women's University, Seoul 01369, Republic of Korea.
- College of Pharmacy, Duksung Women's University, Seoul 01369, Republic of Korea.
- Duksung Innovative Drug Center, Duksung Women's University, Seoul 01369, Republic of Korea.
- Department of Statistics, Duksung Women's University, Seoul 01369, Republic of Korea.
ORCID-Profile: Jihoon Moon, Jehyeok Rew, Hyun Kil Shin, Kyoung Song, Hyosun Cho, Joohee Jung, Minjung Kyung
Förderung
- National Research Foundation of Korea
Zitieren
APA
Moon, J., Rew, J., Shin, H. K., Song, K., Cho, H., Jung, J., & Kyung, M. (2026). Computer-Aided Drug Design for Immunosuppressive Tumor Microenvironment Reprogramming: A Critical Review. International Journal of Molecular Sciences, 27(21), 9766. https://doi.org/10.3390/ijms27219766
Vancouver
Moon J, Rew J, Shin HK, Song K, Cho H, Jung J, et al. Computer-Aided Drug Design for Immunosuppressive Tumor Microenvironment Reprogramming: A Critical Review. International Journal of Molecular Sciences. 2026;27(21):9766. doi:10.3390/ijms27219766
BibTeX
@article{Moon2026,
author = {Moon, Jihoon and Rew, Jehyeok and Shin, Hyun Kil and Song, Kyoung and Cho, Hyosun and Jung, Joohee and Kyung, Minjung},
title = {Computer-Aided Drug Design for Immunosuppressive Tumor Microenvironment Reprogramming: A Critical Review},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9766},
doi = {10.3390/ijms27219766}
}
EUVIMED